RT
Rhinal Therapeutics Inc.
SEC filingBiotechnology · Las Vegas, NV
Amount raised$20Ksold at filing
Total offering$1M$980K still open
Investors in the raise1count reported to the SEC
FiledAug 7, 2025first sale Jul 28, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Lawrence FoxExecutive Officer, Director
Mike GeorgeDirector
Austin PanhansExecutive Officer
Frank PuglisiExecutive Officer, Director
Robert ClayboroughExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.